About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

GIP-A

Company: University Hospital, Gentofte, Copenhagen
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 36 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

36 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Recruiting NCT NCT00992901

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Not yet reported The University of Texas Health Science Center at San Antonio 160 participants Est. completion 2027-08 2 sites

Other conditions: Post Bariatricsurgery, Hypoglycemia
View official trial listing →
Recruiting NCT NCT01851694

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Not yet reported University of Pennsylvania 45 participants Est. completion 2026-12 1 site

Other conditions: Cystic Fibrosis, Pancreatic Insufficiency
View official trial listing →
Recruiting NCT NCT05375968

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

Not yet reported Vanderbilt University Medical Center 50 participants Est. completion 2028-06-01 1 site

Other conditions: Postural Tachycardia Syndrome (POTS)
View official trial listing →
Recruiting NCT NCT05662189

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

Not yet reported Azienda Ospedaliero-Universitaria di Parma 70 participants Est. completion 2025-12 1 site

Other conditions: Type1diabetes, Type2diabetes, Pre Diabetes, Hyperinsulinism
View official trial listing →
Recruiting NCT NCT06191848

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

Not yet reported University of Melbourne 352 participants Est. completion 2037-05 4 sites

Osteoarthritis Other conditions: Obesity
View official trial listing →
Recruiting NCT NCT06518837

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Not yet reported Rutgers, The State University of New Jersey 40 participants Est. completion 2027-09-30 7 sites

Other conditions: Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
View official trial listing →
Recruiting NCT NCT06630585

GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes

Not yet reported University of Bern 42 participants Est. completion 2026-06 3 sites

Other conditions: Type 1 Diabetes (T1D)
View official trial listing →
Recruiting NCT NCT06751589

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2027-12 7 sites

Other conditions: Endometrial Cancer
View official trial listing →
Recruiting NCT NCT06774079

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Not yet reported University of Miami 24 participants Est. completion 2027-03-05 1 site

Other conditions: Crohn Disease
View official trial listing →
Recruiting NCT NCT06888167

Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.

Not yet reported Azienda Ospedaliero-Universitaria di Parma 40 participants Est. completion 2026-02-28 1 site

Other conditions: Healthy Volunteer
View official trial listing →
Recruiting NCT NCT06934473

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Not yet reported University Hospital, Gentofte, Copenhagen 16 participants Est. completion 2026-01-31 2 sites

Other conditions: Bloodpressure
View official trial listing →
Recruiting NCT NCT06939088

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Not yet reported Anders Fink-Jensen, MD, DMSci 108 participants Est. completion 2028-12-31 2 sites

Alcohol use disorder Other conditions: Alcohol Abuse/Dependence, Alcoholism, Schizophrenia Disorders, Schizophrenia and Disorders With Psychotic Features, Schizophrenia and Schizophrenia Spectrum Psychosis, Schizophrenia
View official trial listing →
Recruiting NCT NCT07086963

Is Dorsal Inlay Graft (DIG) With TIP Repair Superior to TIP Alone for Primary Hypospadias?

Not yet reported Mohammad Daboos 584 participants Est. completion 2025-08-08 1 site

Other conditions: Hypospadias
View official trial listing →
Recruiting NCT NCT07127354

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Not yet reported The Cleveland Clinic 132 participants Est. completion 2026-08 3 sites

Other conditions: GLP - 1, Bowel Preparation for Colonoscopy
View official trial listing →
Recruiting NCT NCT07169851

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Not yet reported Eli Lilly and Company 204 participants Est. completion 2027-02 68 sites

Other conditions: Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
View official trial listing →
Recruiting NCT NCT07215559

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Not yet reported Eli Lilly and Company 200 participants Est. completion 2027-05 42 sites

Type 2 diabetes Other conditions: Obesity, Overweight
View official trial listing →
Recruiting NCT NCT07284511

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Not yet reported, Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 105 participants Est. completion 2029-01 4 sites

Other conditions: Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes Mellitus
View official trial listing →
Recruiting NCT NCT07284875

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Not yet reported Kailera 2340 participants Est. completion 2028-03 104 sites

Other conditions: Obesity, Overweight
View official trial listing →
Recruiting NCT NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Not yet reported Kailera 1156 participants Est. completion 2028-04-24 167 sites

Other conditions: Obesity With Diabetes, Overweight With Diabetes
View official trial listing →
Recruiting NCT NCT07284979

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Not yet reported Kailera 1200 participants Est. completion 2028-04 59 sites

Other conditions: Obesity
View official trial listing →
Recruiting NCT NCT07362654

Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease

Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 51 participants Est. completion 2026-11 1 site

Other conditions: Celiac Disease, Gluten Sensitivity, Autoimmune Diseases
View official trial listing →
Recruiting NCT NCT07364175

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2029-01 1 site

Other conditions: Hypertension, Obesity & Overweight
View official trial listing →
Recruiting NCT NCT07373834

Tirzepatide and Muscle Outcomes in Obesity

Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2027-03 1 site

Other conditions: Obesity (Disorder)
View official trial listing →
Recruiting NCT NCT07393360

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Not yet reported Pharmanutra S.p.a. 144 participants Est. completion 2026-12 3 sites

Other conditions: Obesity & Overweight
View official trial listing →
Recruiting NCT NCT07398300

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

Not yet reported Rigshospitalet, Denmark 36 participants Est. completion 2027-05 1 site

Type 2 diabetes Other conditions: Healhty
View official trial listing →
Recruiting NCT NCT07411560

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

Not yet reported Novo Nordisk A/S 100 participants Est. completion 2027-01-26 1 site

Other conditions: Overweight, Obese
View official trial listing →
Recruiting NCT NCT07457437

Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment

Not yet reported University of Exeter 60 participants Est. completion 2027-12-01 1 site

Other conditions: Muscle Mass and Strength, Obesity & Overweight, Physical Function
View official trial listing →
Recruiting NCT NCT07467447

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Not yet reported Hudson Biotech 300 participants Est. completion 2028-02-17 1 site

Other conditions: Obesity
View official trial listing →
Recruiting NCT NCT07481747

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Not yet reported Hudson Biotech 2539 participants Est. completion 2028-03-17 1 site

Type 2 diabetes Other conditions: Obesity
View official trial listing →
Recruiting NCT NCT07484061

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Not yet reported Olistic Research Labs S.L. 40 participants Est. completion 2026-10-31 1 site

Other conditions: Telogen Effluvium
View official trial listing →
Recruiting NCT NCT07554638

Incretin Therapies in Obesity-related HFpEF

Not yet reported Columbia University 50 participants Est. completion 2030-04 1 site

Heart failure Other conditions: Obesity
View official trial listing →
Recruiting NCT NCT07653412

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

National and Kapodistrian University of Athens 220 participants Est. completion 2027-06-30 1 site

Other conditions: Obesity (Disorder), Anti-obesity Agents, Precision Medicine
View official trial listing →
Recruiting NCT NCT07685808

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Not yet reported Regeneron Pharmaceuticals 360 participants Est. completion 2028-01-21 5 sites

Other conditions: Overweight or Obesity
View official trial listing →
Recruiting NCT NCT07721597

A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

Not yet reported Zealand Pharma 88 participants Est. completion 2027-09-06 1 site

Other conditions: Healthy Participants Study, Overweight and Obese Adults, First in Man Study to Evaluate Initial Safety
View official trial listing →
Recruiting NCT NCT07740291

Tirzepatide Impact Assessment Study

Not yet reported Texas Tech University 27 participants Est. completion 2026-12-07 1 site

Other conditions: Obesity & Overweight, Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health
View official trial listing →
Recruiting NCT NCT07760896

The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness

Not yet reported Saundra Jain 200 participants Est. completion 2027-10 1 site

Other conditions: Wellness
View official trial listing →
Status unknown NCT NCT00127049

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 37 participants 1 site

Other conditions: Germ Cell Tumor
View official trial listing →
Terminated NCT NCT00207389

A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients

Boston Medical Center 5 participants Est. completion 2006-08 1 site

Type 2 diabetes Other conditions: Obesity, Insulin Resistance
View official trial listing →
Completed NCT NCT00239707

GIP: Glucose-dependent Insulinotropic Peptide

Not yet reported National Institute on Aging (NIA) 41 participants Est. completion 2006-12 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT00302302

The Effects of L-arabinose on Intestinal Sucrase Activity in Man

Not yet reported University of Copenhagen 15 participants Est. completion 2006-01 1 site

Other conditions: Blood Glucose
View official trial listing →
Completed NCT NCT00488423

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

Not yet reported The Cleveland Clinic 21 participants Est. completion 2008-11 1 site

Other conditions: Diabetes, Gastric Bypass
View official trial listing →
Completed NCT NCT00566189

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Not yet reported, Not yet reported University of Campinas, Brazil 36 participants Est. completion 2012-12 1 site

Type 2 diabetes Other conditions: Insulin Resistance, Obesity
View official trial listing →
Terminated NCT NCT00566215

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Not yet reported, Not yet reported University of Campinas, Brazil 6 participants Est. completion 2009-06 1 site

Type 2 diabetes Other conditions: Insulin Resistance, Obesity
View official trial listing →
Completed NCT NCT00566358

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Not yet reported, Not yet reported University of Campinas, Brazil 18 participants Est. completion 2009-06 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT00612950

Beta-Cell Function After Near-Normalisation of Blood Glucose

Not yet reported Hvidovre University Hospital 8 participants Est. completion 2007-05 1 site

Type 2 diabetes
View official trial listing →
Terminated NCT NCT00625040

Incretin Physiology and Beta-cell Function Before and After Weight-loss

Glostrup University Hospital, Copenhagen 10 participants Est. completion 2011-01 1 site

Other conditions: Obesity
View official trial listing →
Completed NCT NCT00639613

The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia

University Hospital, Gentofte, Copenhagen 20 participants 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT00716170

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Herlev Hospital 10 participants Est. completion 2009-07 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT00732602

The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes

Not yet reported University Hospital, Gentofte, Copenhagen 8 participants 1 site

Other conditions: Diabetes Mellitus
View official trial listing →
Completed NCT NCT00774488

Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose Tissue

Not yet reported German Institute of Human Nutrition 17 participants Est. completion 2007-07

Metabolic syndrome Other conditions: Obesity, Insulin Sensitivity
View official trial listing →
Completed NCT NCT00784745

Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect

Not yet reported University Hospital, Gentofte, Copenhagen 21 participants Est. completion 2009-09 1 site

Other conditions: Insulin Resistance, Glucose Intolerance
View official trial listing →
Status unknown NCT NCT00809029

The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study

Not yet reported Liverpool University Hospitals NHS Foundation Trust 12 participants Est. completion 2012-12 1 site

Other conditions: Adipose Tissue
View official trial listing →
Completed NCT NCT00817973

Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein

Not yet reported Aarhus University Hospital 12 participants 1 site

Type 2 diabetes Other conditions: Postprandial Lipemia
View official trial listing →
Completed NCT NCT00843232

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

University of Campinas, Brazil 24 participants Est. completion 2010-09 1 site

Type 2 diabetes Other conditions: Insulin Resistance
View official trial listing →
Completed NCT NCT00999271

Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

Hvidovre University Hospital 30 participants Est. completion 2009-09 1 site

Other conditions: Healthy Subjects
View official trial listing →
Completed NCT NCT01087372

Stress Hyperglycemia. Potential Role of Incretin Analogs

Hospital Universitari Son Dureta 60 participants Est. completion 2010-04 1 site

Other conditions: Hyperglycemia, Critical Illness
View official trial listing →
Completed NCT NCT01173978

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2010-07 1 site

Other conditions: Insulin Resistance, Deteriorated Glucose Homeostasis, Inactivity
View official trial listing →
Completed NCT NCT01189890

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Not yet reported Merck Sharp & Dohme LLC 480 participants Est. completion 2012-10-31

Type 2 diabetes
View official trial listing →
Completed NCT NCT01274052

Study of Postprandial Incretin Response in Women With Gestational Diabetes

University Hospital, Gentofte, Copenhagen 19 participants Est. completion 2008-07 1 site

Other conditions: Gestational Diabetes Mellitus
View official trial listing →
Completed NCT NCT01305291

Fibersol-2 Clinical Trials Related to Appetite

Not yet reported Iowa State University 20 participants Est. completion 2009-11 1 site

Other conditions: Lack of Satiety
View official trial listing →
Completed NCT NCT01375270

Glucolipotoxicity and Type 2 Diabetes

Not yet reported Rigshospitalet, Denmark 30 participants Est. completion 2014-12 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT01408862

Effects of Incretins on Human Platelet Function

National Council of Scientific and Technical Research, Argentina 20 participants Est. completion 2014-08

Other conditions: Inhibition of Platelet Aggregation by Incretins
View official trial listing →
Completed NCT NCT01434901

The Effects of Bethanechol on Glucose Homeostasis

Not yet reported Washington University School of Medicine 50 participants Est. completion 2014-07-07 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT01571622

Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes

Not yet reported Tel Aviv University 19 participants Est. completion 2013-09 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT01607931

Exercise, Glucose Kinetics, and the Incretin Effect

Not yet reported Rigshospitalet, Denmark 12 participants Est. completion 2016-07 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT01694004

Nutrient Sensing in the Duodenum

Not yet reported Vanderbilt University Medical Center 16 participants Est. completion 2014-10-27 1 site

Other conditions: The Effect of LCFA on Nutrient Absorption
View official trial listing →
Completed NCT NCT01779622

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

Not yet reported Lund University 24 participants Est. completion 2014-06 1 site

Other conditions: Healthy Volunteers Recruited From the General Population
View official trial listing →
Completed NCT NCT01901861

Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes

Not yet reported Lund University 12 participants Est. completion 2015-12 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT01906359

Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers

Not yet reported Malaysia Palm Oil Board 23 participants Est. completion 2014-03 5 sites

Type 2 diabetes
View official trial listing →
Withdrawn NCT NCT01951716

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Not yet reported Washington University School of Medicine Est. completion 2018-07 1 site

Other conditions: Does the Vagus Nerve Mediate the Effects of Xenin-25
View official trial listing →
Completed NCT NCT01951729

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Not yet reported Washington University School of Medicine 15 participants Est. completion 2015-05 1 site

Prediabetes
View official trial listing →
Completed NCT NCT01975259

Investigating the Incretin Effect in Cystic Fibrosis

Liverpool Heart and Chest Hospital NHS Foundation Trust 50 participants Est. completion 2015-07 1 site

Other conditions: Cystic Fibrosis
View official trial listing →
Completed NCT NCT01999504

Gut Hormone Response After Paleolithic-type Meals

Not yet reported Unilever R&D 24 participants Est. completion 2014-10 1 site

Other conditions: Insulin Resistance, Satiety
View official trial listing →
Completed NCT NCT02000011

Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study

Not yet reported Assistance Publique Hopitaux De Marseille 50 participants Est. completion 2022-10-27 1 site

Other conditions: Cancer
View official trial listing →
Completed NCT NCT02021903

Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies

Not yet reported University Hospital, Toulouse 21 participants Est. completion 2020-06 2 sites

Other conditions: Parkinsonian Disorders
View official trial listing →
Completed NCT NCT02180620

Pre-dinner vs. Post-dinner Exercise on Glycemic Control

Not yet reported University of Missouri-Columbia 13 participants Est. completion 2014-04

Type 2 diabetes
View official trial listing →
Completed NCT NCT02180646

Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes

Not yet reported University of Missouri-Columbia 12 participants Est. completion 2013-04

Type 2 diabetes
View official trial listing →
Completed NCT NCT02219295

SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

Not yet reported German Institute of Human Nutrition 97 participants Est. completion 2014-09 1 site

Other conditions: Disorder of Glucose Regulation
View official trial listing →
Completed NCT NCT02235584

Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

Not yet reported Hvidovre University Hospital 19 participants 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT02264951

Fat-induced Release of GLP-1 in Humans

Not yet reported Glostrup University Hospital, Copenhagen 12 participants Est. completion 2014-02

Type 2 diabetes
View official trial listing →
Status unknown NCT NCT02365740

Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options

Not yet reported Federico II University 80 participants Est. completion 2016-11 1 site

Other conditions: Diabetes Mellitus, Type 1
View official trial listing →
Completed NCT NCT02389062

Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients

Not yet reported Thomas Jefferson University 5 participants Est. completion 2017-02-11 1 site

Other conditions: Adult Form of Celiac Disease
View official trial listing →
Completed NCT NCT02398383

Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes

Not yet reported Yale University 7 participants Est. completion 2017-06-22 1 site

Other conditions: Cystic Fibrosis, Cystic Fibrosis Related Diabetes
View official trial listing →
Completed NCT NCT02518737

Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity

University of Copenhagen 36 participants Est. completion 2016-06 1 site

Other conditions: Bone Remodeling
View official trial listing →
Completed NCT NCT02550548

Incretin Action in Physiology and Diabetes

Not yet reported David D'Alessio, M.D. 39 participants Est. completion 2021-04-16 1 site

Other conditions: Insulin Secretion
View official trial listing →
Completed NCT NCT02639130

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Not yet reported Diabeteszentrum Bad Lauterberg im Harz 67 participants Est. completion 2010-01 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT02673554

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Not yet reported Diabeteszentrum Bad Lauterberg im Harz 30 participants

Type 2 diabetes
View official trial listing →
Completed NCT NCT02697305

Incretin Effects of Branched Chain Amino Acids

Not yet reported Charles University, Czech Republic 18 participants Est. completion 2015-12 1 site

Other conditions: Glucose Metabolism Disorders
View official trial listing →
Completed NCT NCT02747472

GIP Receptor Antagonist Studies in Humans

Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2016-07 1 site Stand-alone

Other conditions: Glucose Metabolism
View official trial listing →
Completed NCT NCT03013296

Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2018-09 1 site

Other conditions: Glucose Metabolism Disorders
View official trial listing →
Completed NCT NCT03133741

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2017-07-01 1 site

Other conditions: Glucose Metabolism Disorders
View official trial listing →
Suspended NCT NCT03462979

Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease

Not yet reported Boston Children's Hospital 120 participants Est. completion 2023-12-31 1 site

Other conditions: Celiac Disease, Gluten Sensitivity, Gluten Enteropathy, Gastrointestinal Disease, Digestive System Disease, Diet Modification, Intestinal Disease, Malabsorption Syndromes, Patient Compliance, Diagnostic Self Evaluation, Quality of Life
View official trial listing →
Completed NCT NCT03556098

Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes

Not yet reported Steno Diabetes Center Copenhagen 12 participants Est. completion 2020-02-11 1 site

Other conditions: Diabetes Mellitus, Type 1
View official trial listing →
Completed NCT NCT03702660

Effect of GIP After a Meal in Patients With Type 2 Diabetes

Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2018-01-23 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT03714594

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

Not yet reported University of Pisa 48 participants Est. completion 2022-08-31 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT03728959

Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.

Not yet reported University of Copenhagen 7 participants Est. completion 2019-04-12 1 site

Other conditions: Hypoparathyroidism
View official trial listing →
Completed NCT NCT03730662

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Not yet reported Eli Lilly and Company 2002 participants Est. completion 2021-04-22 216 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT03806920

Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect

Not yet reported German Institute of Human Nutrition 50 participants Est. completion 2019-07-30 1 site

Type 2 diabetesMetabolic syndrome
View official trial listing →
Completed NCT NCT03807076

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

Not yet reported University of Copenhagen 25 participants Est. completion 2023-11-28 1 site

Other conditions: Acromegaly Due to Pituitary Adenoma
View official trial listing →
Completed NCT NCT03829800

Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes

Not yet reported Universidad del Zulia 23 participants Est. completion 2018-11-15

Type 2 diabetes
View official trial listing →
Completed NCT NCT03950245

Incretin Hormone Antagonism After Bariatric Surgery

Not yet reported Hvidovre University Hospital 36 participants Est. completion 2021-04-16 2 sites

Other conditions: Bariatric Surgery
View official trial listing →
Completed NCT NCT03954834

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Not yet reported Eli Lilly and Company 478 participants Est. completion 2020-10-28 53 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT03987919

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Not yet reported Eli Lilly and Company 1879 participants Est. completion 2021-02-15 127 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT04039503

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Not yet reported Eli Lilly and Company 475 participants Est. completion 2021-01-13 48 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT04056286

Gastro-intestinal and Hormonal Responses to Systemic Inflammatory Disease

Not yet reported University of Aarhus 8 participants Est. completion 2020-01-23 1 site

Other conditions: Motility Disorder, Catabolic State, Endotoxemia
View official trial listing →
Completed NCT NCT04255433

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Not yet reported Eli Lilly and Company 13299 participants Est. completion 2025-06-12 635 sites

Type 2 diabetes
View official trial listing →
Completed NCT NCT04537923

A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

Not yet reported Eli Lilly and Company 1428 participants Est. completion 2022-11-01 135 sites

Type 2 diabetes
View official trial listing →
Active, not recruiting NCT NCT04765800

Differential Efficacy of Guided Imagery Psychotherapy: Non-Inferiority Trial and Exploration of Differential Indication

Not yet reported University of Kassel 180 participants Est. completion 2029-06-30 1 site

Other conditions: Emotional Disorders
View official trial listing →
Completed NCT NCT04792762

Physiology of GIP(1-30)NH2 in Humans

Not yet reported University Hospital, Gentofte, Copenhagen 9 participants Est. completion 2019-06-09 1 site

Other conditions: Glucose Metabolism Disorders
View official trial listing →
Completed NCT NCT04926415

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Not yet reported Burrell College of Health Sciences 30 participants Est. completion 2022-04-26 1 site

Type 2 diabetes Other conditions: Obesity
View official trial listing →
Suspended NCT NCT05119322

Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence

Not yet reported Biomedal S.L. 66 participants Est. completion 2027-12-31 1 site

Other conditions: Celiac Disease, Treatment Adherence, Adolescent
View official trial listing →
Completed NCT NCT05186038

Mass Screening for the Early Detection of Patients With Celiac Disease.

Biomedal S.L. 1000 participants Est. completion 2022-12-31 2 sites

Other conditions: Celiac Disease
View official trial listing →
Completed NCT NCT05203237

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Not yet reported Viking Therapeutics, Inc. 92 participants Est. completion 2024-12-03 1 site

MASH Other conditions: Weight Loss
View official trial listing →
Enrolling by invitation NCT NCT05204446

Behavioral Intervention for Celiac Disease

Not yet reported Children's National Research Institute 96 participants Est. completion 2026-10-01 1 site

Other conditions: Celiac Disease
View official trial listing →
Completed NCT NCT05260021

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Not yet reported Eli Lilly and Company 99 participants Est. completion 2025-01-28 51 sites

Type 2 diabetes Other conditions: Diabetes Mellitus, Glucose Metabolism Disorders, Endocrine System Diseases, Metabolic Disease
View official trial listing →
Completed NCT NCT05391438

Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity

Not yet reported Children's Hospital Los Angeles 22 participants Est. completion 2023-08-01 1 site

Other conditions: Pediatric Obesity, Meal Timing
View official trial listing →
Status unknown NCT NCT05659368

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Not yet reported Ospedale San Raffaele 10 participants Est. completion 2024-12 1 site

Other conditions: Wolfram Syndrome
View official trial listing →
Terminated NCT NCT05762744

Pharmacogenomics of GLP1 Receptor Agonists

Not yet reported University of Maryland, Baltimore 63 participants Est. completion 2022-10-31 1 site

Type 2 diabetes
View official trial listing →
Status unknown NCT NCT05798598

Evaluation of Competencies in Scientific Writing and Attendees' Satisfaction After Two Different Types of Training Courses: SCRIU-B Study

Not yet reported Dr. Antoni Esteve Foundation 270 participants Est. completion 2024-12-31 1 site

Other conditions: Scientific Writing Training Course
View official trial listing →
Completed NCT NCT05835752

The Safety, Tolerability and Pharmacokinetic Study of RAY1225

Not yet reported Guangdong Raynovent Biotech Co., Ltd 68 participants Est. completion 2024-03-23 1 site

Other conditions: Obese, Healthy
View official trial listing →
Completed NCT NCT06068946

VK2735 for Weight Management Phase 2

Not yet reported Viking Therapeutics, Inc. 176 participants Est. completion 2024-04-02 20 sites

Other conditions: Weight Loss
View official trial listing →
Completed NCT NCT06137586

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-05-17 1 site

Other conditions: Type1diabetes, Hypoglycemia, Type 1 Diabetes
View official trial listing →
Not yet recruiting NCT NCT06180616

Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

Not yet reported Royal North Shore Hospital 40 participants Est. completion 2028-12

Other conditions: Type 1 Diabetes Mellitus, Overweight and Obesity
View official trial listing →
Enrolling by invitation NCT NCT06208904

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2025-12-31 1 site

Other conditions: PostPrandial Hypotension
View official trial listing →
Status unknown NCT NCT06301256

Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa

Not yet reported Florida Academic Centers Research and Education, LLC 20 participants Est. completion 2025-03-11

Other conditions: Hidradenitis Suppurativa
View official trial listing →
Status unknown NCT NCT06368752

The Role of Endogenous GIP in Glycosis Metabolism During Fasting

Not yet reported Frederikke Koefoed-Hansen 12 participants Est. completion 2025-12-31 1 site

Other conditions: Obesity
View official trial listing →
Completed NCT NCT06383117

Understanding Effects of Calcium on the Gut-Bone Axis

Not yet reported University of Georgia 14 participants Est. completion 2024-02-23 1 site

Other conditions: Healthy, Adult, Calcium, Bone Resorption, Endocrine; Obesity
View official trial listing →
Status unknown NCT NCT06419686

The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-07 1 site

Other conditions: Effect of iv Administration of GIP and Alanine
View official trial listing →
Completed NCT NCT06445075

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

Not yet reported Scholar Rock, Inc. 102 participants Est. completion 2025-06-17 7 sites

Other conditions: Overweight and Obesity
View official trial listing →
Terminated NCT NCT06515418

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over

Not yet reported BioAge Labs, Inc. 204 participants Est. completion 2025-02-12 14 sites

Other conditions: Obesity
View official trial listing →
Completed NCT NCT06564753

Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

Not yet reported Biomed Industries, Inc. 126 participants Est. completion 2025-04-18 5 sites

Other conditions: Weight Loss, Obesity, Body Weight, Body Weight Changes
View official trial listing →
Active, not recruiting NCT NCT06565611

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

Not yet reported Palatin Technologies, Inc 108 participants Est. completion 2025-03-31 4 sites

Other conditions: Obesity
View official trial listing →
Enrolling by invitation NCT NCT06581120

GLP_1 RA Ultrasound Study

Children's Hospital Medical Center, Cincinnati 100 participants Est. completion 2026-07 1 site

Other conditions: Glucagon Like Peptide-1 (GLP-1, Delayed Gastric Emptying, Risk of Aspiration, Diabetes, Morbid Obesity
View official trial listing →
Active, not recruiting NCT NCT06801015

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

Not yet reported Mayo Clinic 30 participants Est. completion 2028-03-31 1 site

Other conditions: Obesity
View official trial listing →
Completed NCT NCT06818032

Avocado and Postprandial Responses

Not yet reported University of Vermont Medical Center 30 participants Est. completion 2026-03-26 1 site

Other conditions: Healthy, Healthy Volunteer, Healthy Volunteers, Healthy Adult, Healthy Male and Female Subjects, Healthy Subjects, Healthy Volunteers Only, Healthy Non-smokers
View official trial listing →
Completed NCT NCT06828055

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Not yet reported Viking Therapeutics, Inc. 280 participants Est. completion 2025-08-15 15 sites

Other conditions: Weight Loss
View official trial listing →
Completed NCT NCT06893211

Effect of Tirzepatide on Brown Adipose Tissue in Obesity

Not yet reported University Medical Centre Ljubljana 34 participants Est. completion 2025-12-20 1 site

Other conditions: Obesity
View official trial listing →
Completed NCT NCT06901648

A Study of HS-20094 in Patients With T2DM

Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 275 participants Est. completion 2025-04-09 1 site

Type 2 diabetes
View official trial listing →
Active, not recruiting NCT NCT07104383

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Not yet reported Viking Therapeutics, Inc. 1100 participants Est. completion 2027-08-01 127 sites

Other conditions: Weight Loss
View official trial listing →
Completed NCT NCT07104461

Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity

Not yet reported University of Westminster 12 participants Est. completion 2024-10-31 1 site

Other conditions: Appetite and General Nutritional Disorders
View official trial listing →
Active, not recruiting NCT NCT07104500

VK2735 for Weight Management Phase 3

Not yet reported Viking Therapeutics, Inc. 4500 participants Est. completion 2027-08-01 137 sites

Other conditions: Weight Loss
View official trial listing →
Not yet recruiting NCT NCT07117721

Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)

Not yet reported El Katib Hospital 10 participants Est. completion 2029-01-01

Type 2 diabetes
View official trial listing →
Completed NCT NCT07141472

Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study

Not yet reported Lawry Han 69 participants Est. completion 2025-08-14 1 site

Other conditions: Blood Sugar; High, Overweight and Obesity, Fat Loss, GLP-1, Glucagon
View official trial listing →
Not yet recruiting NCT NCT07156331

Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes

Kristin Clemens 20 participants Est. completion 2027-12-31

Type 2 diabetes
View official trial listing →
Completed NCT NCT07235670

Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome

Not yet reported Rigshospitalet, Denmark 39 participants Est. completion 2022-06-16 1 site

Other conditions: Short Bowel Syndrome, Intestinal Resection
View official trial listing →
Completed NCT NCT07240246

Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults

Not yet reported FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation 40 participants Est. completion 2026-05-12 1 site

Other conditions: GLP-1, Obesity &Amp; Overweight, Dietary Supplement
View official trial listing →
Not yet recruiting NCT NCT07288372

The CGM-OGTT Glycemic Homeostasis Study

Shanghai 6th People's Hospital 225 participants Est. completion 2027-08-10

Type 2 diabetes Other conditions: Glucose Metabolism Disorders
View official trial listing →
Not yet recruiting NCT NCT07292519

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

Not yet reported South West Sydney Local Health District 46 participants Est. completion 2028-01-15 1 site

Alcohol use disorder Other conditions: Overweight or Obese, Comorbidities and Coexisting Conditions
View official trial listing →
Active, not recruiting NCT NCT07303556

Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs

Not yet reported Nazarbayev University 120 participants Est. completion 2026-11-01 1 site

Heart failure Other conditions: Diabete Type 2, Arterial Hypertension
View official trial listing →
Not yet recruiting NCT NCT07336901

Adductor Canal Block and IPACK Block vs Adductor Canal Block and the Gastrosoleus Interfascial Block After Total Knee Arthroplasty

Not yet reported Fayoum University Hospital 86 participants Est. completion 2026-10

Other conditions: Pain After Knee Arthroplasty
View official trial listing →
Active, not recruiting NCT NCT07431086

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

Not yet reported Regeneron Pharmaceuticals 120 participants Est. completion 2026-12-18 3 sites

Other conditions: Overweight or Obesity
View official trial listing →
Active, not recruiting NCT NCT07458269

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

Not yet reported Kailera 264 participants Est. completion 2027-06 35 sites

Other conditions: Obesity
View official trial listing →
Completed NCT NCT07475143

A Comparative Study Between Effect Of Mini-gastric Bypass and Single Anastmosis Sleeve Jujenal Bypass On Levels Of GLP-1, GIP, PYY, Insulin Resistance and Type II DM Resolution

Not yet reported Ain Shams University 40 participants Est. completion 2025-03-15 1 site

Other conditions: Incretin Hormones Plasma Levels, Gastric Bypass Surgery
View official trial listing →
Not yet recruiting NCT NCT07483801

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

Not yet reported Cambridge University Hospitals NHS Foundation Trust 112 participants Est. completion 2028-04 1 site

Cardiovascular disease
View official trial listing →
Not yet recruiting NCT NCT07567378

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

JULIO GRANADOS MONTIEL 30 participants Est. completion 2029-05 1 site

Type 2 diabetesMetabolic syndromeHeart failureCardiovascular disease Other conditions: Psoriatic Arthritis, Osteoarthitis, Knee, Diabetes (DM), Obesity (Disorder), Insulin Resistance Syndrome, Preserved Ejection Fraction, Atrial Fibrillation (AF), Non Alcholic Fatty Liver Disease, Sarcopenia, Pericardium
View official trial listing →
Not yet recruiting NCT NCT07578038

Interest of Urinary Measurement of Immunogenic Gluten Peptides (GIP) in the Follow-up of Pediatric Celiac Patients.

Not yet reported Fondation Lenval 100 participants Est. completion 2029-06 1 site

Other conditions: Coeliac Disease
View official trial listing →
Not yet recruiting NCT NCT07609160

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

Not yet reported Acibadem University 108 participants Est. completion 2028-01-01

Type 2 diabetes Other conditions: Obesity, Sarcopenia
View official trial listing →
Completed NCT NCT07625319

Gut Hormones and Nutritional Status After a Standardized Meal.

Not yet reported Medical University of Bialystok 80 participants Est. completion 2026-04-14 1 site

Other conditions: Obesity
View official trial listing →
Not yet recruiting NCT NCT07630454

Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Not yet reported Yunlong Wang 602 participants Est. completion 2029-12-01 1 site

Heart failure Other conditions: Atrial Fibrillation, Tirzepatide
View official trial listing →
Enrolling by invitation NCT NCT07640139

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

Indiana University 125000 participants Est. completion 2029-12-31 1 site

Other conditions: Obesity
View official trial listing →
Not yet recruiting NCT NCT07676331

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Not yet reported Universitaire Ziekenhuizen KU Leuven 168 participants Est. completion 2028-05-01

Other conditions: Hormone-receptor-positive Breast Cancer, Early Breast Cancer
View official trial listing →
Not yet recruiting NCT NCT07679516

Postprandial Regulation of Bone Perfusion in Healthy Individuals

Not yet reported University of Copenhagen 15 participants Est. completion 2028-05 1 site

Other conditions: Healthy Adult Participants, Bone Physiology, Bone Blood Flow Regulation, Peptide Hormones
View official trial listing →
Enrolling by invitation NCT NCT07687589

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

Not yet reported University of Copenhagen 14 participants Est. completion 2027-04-28 1 site

Other conditions: Emesis
View official trial listing →
Completed NCT NCT07701005

Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity

Goztepe Prof Dr Suleyman Yalcın City Hospital 154 participants Est. completion 2026-04-15 1 site

Other conditions: Steatosis of Liver, Metabolic Liver Injury, Obesity, Overweight, Insulin Resistance
View official trial listing →
Not yet recruiting NCT NCT07715929

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Not yet reported Yunlong Wang 710 participants Est. completion 2029-12-30

Other conditions: Atrial Fibrillation, Obesity & Overweight, Catheter Ablation
View official trial listing →
Not yet recruiting NCT NCT07734792

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

Not yet reported, Not yet reported yifang zhu 430 participants Est. completion 2028-07-31 1 site

Cardiovascular disease
View official trial listing →
Not yet recruiting NCT NCT07738276

Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity

Not yet reported Shahid Beheshti University of Medical Sciences 60 participants Est. completion 2027-12-22

Heart failure Other conditions: Obesity & Overweight, Tirzepatide
View official trial listing →
Not yet recruiting NCT NCT07747805

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Not yet reported The Cleveland Clinic 30 participants Est. completion 2029-08-15 1 site

Other conditions: COPD, Obesity & Overweight, Sarcopenia
View official trial listing →
Not yet recruiting NCT NCT07756359

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)

Not yet reported University of North Carolina, Chapel Hill 20 participants Est. completion 2027-09 5 sites

Other conditions: Pouch, Ileal, Pouches, Ileoanal, Bowel Diseases, Inflammatory
View official trial listing →
Not yet recruiting NCT NCT07767942

UBT251 Injection Phase Ⅲ Study (OSA-NPAP)

Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 150 participants Est. completion 2028-10

Obstructive sleep apnea
View official trial listing →
Not yet recruiting NCT NCT07777575

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Not yet reported Technical University of Munich 150 participants Est. completion 2027-05-31 1 site

Other conditions: Obesity (BMI>30)
View official trial listing →
Not yet recruiting NCT NCT07787936

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Miedziowe Centrum Zdrowia SA 150 participants Est. completion 2033-01-01 1 site

Heart failure Other conditions: Obesity, Pulmonary Hypertension, Iron Deficiency
View official trial listing →
Not yet recruiting NCT NCT07793929

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Not yet reported Kailera 32 participants Est. completion 2028-02-08 1 site

Other conditions: End Stage Renal Disease, Renal Impairment, Obesity, Overweight
View official trial listing →
Not yet recruiting NCT NCT07806851

UBT251 Injection Phase Ⅲ Study (OSA-PAP)

Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 150 participants Est. completion 2029-04

Obstructive sleep apnea Other conditions: Obesity
View official trial listing →
Not yet recruiting NCT NCT07811895

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Not yet reported RenJi Hospital 1510 participants Est. completion 2030-12 1 site

Other conditions: Tirzepatide, Frozen Embryo Transfer, Obesity
View official trial listing →
Not yet recruiting NCT NCT07812636

Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer

Not yet reported Milton S. Hershey Medical Center 15 participants Est. completion 2028-08-01 1 site

Other conditions: Grade 1 Endometrial Endometrioid Carcinoma, Endometrial Intraepithelial Neoplasia, Metabolic Comorbidities
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT02747472

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.